Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)-Reference-Cited by-同舟云学术

Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)

Published:2010-06-21 Issue:3 Volume:13 Page:246-252
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:

Author:

DAVATCHI Fereydoun,SHAMS Hormoz,REZAIPOOR Mozhgan,SADEGHI-ABDOLLAHI Bahar,SHAHRAM Farhad,NADJI Abdolhadi,CHAMS-DAVATCHI Cheyda,AKHLAGHI Massoomeh,FAEZI Tahereh,NADERI Nasim

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1756-185X.2010.01546.x/fullpdf

Reference51 articles.

1. How to deal with Behcet’s Disease in the daily practice;Davatchi;Int J Rheum Dis,2010

2. Behçet’s disease and immunosuppressive treatment. Our personal experience;Bietti;Mod Probl Ophthalmol,1976

3. Results of immunosuppressive treatment in Bechçet’s disease: report of 55 cases;Firat;Ann Ophthalmol,1978

4. Immunosuppressive therapy of Behcet’s syndrome. Long term follow-up evaluation (author’s transl);Bonnet;J Fr Ophtalmol,1981

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of immunomodulators in non-infectious uveitis: lights and shadows;Eye;2024-08-19

2. Recent advances in the diagnosis and management of Behçet’s syndrome uveitis;Expert Review of Ophthalmology;2024-08-17

3. Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond;Frontiers in Ophthalmology;2024-08-02

4. Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances;Journal of Neuroinflammation;2024-05-22

5. Indications, response, and side effects of biologic treatment in Behçet’s disease: an 8-year study with follow-up;Rheumatology;2024-04-05